The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
She described being told to lose weight at a "humiliating" nude line-up as more stars speak out after Harvey Weinstein scandal.
It is "unthinkable" that the UK will walk from Brexit talks without a deal at least covering security, Home Secretary Amber Rudd has said.
Ulster rugby stars Paddy Jackson and Stuart Olding are to stand trial on charges of rape, a Belfast court has ruled.